Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,264 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

NCT06116110

Conditions
Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations
  • Stanford University Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

NCT07188558

Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 36 locations
View Trial Details
Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
View all 175 locations
View Trial Details
Recruiting

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

NCT07424833

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • START Los Angele Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT07197307

Conditions
Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
Locations
  • Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany
  • Universitaetsklinikum Aachen Aachen, Germany
  • Universitaetsklinikum Augsburg Augsburg, Germany
  • Vivantes Netzwerk fuer Gesundheit Berlin, Germany
View all 34 locations
View Trial Details
Recruiting

Long-term Follow up Local Registry Study of Kymriah in South Korea

NCT06785818

Conditions
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
  • Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Gyeonggi-do, Korea, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
View all 18 locations
View Trial Details

Related conditions